Cardurion Pharmaceuticals is a biotechnology company that specializes in the discovery and development of therapies intended for cardiovascular disease. Cardurion Pharmaceuticals was founded in 2017 and is headquartered in Burlington, MA. Striving to address the unique needs of patients suffering from heart disease through novel approaches, the team manages the development and clinical trial stages for patients suffering from chronic heart failure along with related therapies that have broad potential for cardiovascular disease treatment.
Cardurion Pharma is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
Cardurion Pharma has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.
Cardurion Pharma is privately held company and is not publicly traded, therefor investing in Cardurion Pharma pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.
To determine the value of your Cardurion Pharma shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Cardurion Pharma shares. You can also learn more about how to sell your private shares before getting started.
Yes, you can seek to sell shares in Cardurion Pharma while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.
Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
---|---|---|---|---|
7/16/2024 | Series B |
$260.41MM raised | $XXX.XX | $XXX.XX |
7/14/2023 | Series A-5 |
$47.5MM raised | $XXX.XX | $XXX.XX |
10/27/2021 | Series A-3 and A-4 |
$131.35MM raised | $XXX.XX | $XXX.XX |
11/20/2019 | Series A-1 |
$46.12MM raised | $XXX.XX | $XXX.XX |
3/20/2017 | Series A-2 |
$14.46MM raised | $XXX.XX | $XXX.XX |